Can nabilone be used to treat anxiety?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Nabilone for Anxiety: Not Recommended as First-Line Treatment

Nabilone is not recommended for the treatment of anxiety disorders due to lack of FDA approval for this indication, significant side effect profile, and availability of better-established treatment options. 1, 2

Safety Concerns and Contraindications

  • Nabilone can cause significant adverse effects including drowsiness (66% of patients), vertigo/dizziness (59%), euphoria (38%), dry mouth (22%), and concentration difficulties (12%) 2
  • Postural hypotension and tachycardia are common cardiovascular effects, requiring caution in elderly patients and those with hypertension or heart disease 2
  • Nabilone should be used with caution in patients with current or previous psychiatric disorders as it may unmask symptoms of depression, schizophrenia, or other mental health conditions 2
  • The drug has potential for additive CNS depression when combined with sedatives, hypnotics, or other psychoactive medications 2
  • There is potential for substance abuse, particularly in patients with a history of alcohol or marijuana dependence 2, 3

Evidence for Anxiety Treatment

  • While nabilone has mild anxiolytic properties as noted in some studies, this is considered a secondary effect and not its primary mechanism of action 4, 5
  • A 1978 study comparing nabilone (2mg) to diazepam (5mg) found that anxiety induced by experimental procedures was alleviated by diazepam and, to a lesser extent, by nabilone 5
  • No consensus exists among expert panels regarding the appropriateness of nabilone for anxiety management 6
  • The American Geriatrics Society recommends immediate dose reduction when moderate to severe dizziness affects daily activities or when falls occur in patients taking nabilone 7

Established Alternatives for Anxiety Treatment

  • First-line pharmacological treatments for anxiety disorders include:
    • Selective serotonin reuptake inhibitors (SSRIs)
    • Serotonin-norepinephrine reuptake inhibitors (SNRIs) 8
  • Benzodiazepines have substantial evidence supporting their use in panic disorder and generalized anxiety disorder, though concerns about dependence limit long-term use 1, 8
  • Cognitive behavioral therapy (CBT) is a well-established non-pharmacological treatment for anxiety disorders with strong evidence of efficacy 1

Risk Management if Considering Off-Label Use

  • If considering nabilone for off-label use despite these concerns:
    • Start with lower doses (0.5mg daily) and monitor closely for side effects, particularly in older adults 7
    • Regular assessment of orthostatic vital signs is recommended before and during therapy 7
    • Avoid abrupt discontinuation; tapering is recommended to prevent withdrawal symptoms 1, 2
    • Patients should be warned not to drive, operate machinery, or engage in hazardous activities while taking nabilone 2
    • Patients should remain under supervision of a responsible adult while using nabilone 2

Common Pitfalls and Caveats

  • Nabilone may cause disorientation (2% of patients) and depersonalization (2% of patients), which could worsen anxiety symptoms in some patients 2
  • Tolerance to euphoria and dry mouth develops after a few days of use, but relaxation effects may persist 9
  • The risk of drug interactions is significant, particularly with CNS depressants, which could lead to additive drowsiness and CNS depression 2
  • Patients with anxiety disorders often have comorbid conditions that may be exacerbated by nabilone's side effect profile 8
  • Cannabis withdrawal syndrome can occur with abrupt cessation of nabilone, potentially worsening anxiety 6

References

Guideline

Nabilone for Anxiety: Evidence and Recommendations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The abuse potential of the synthetic cannabinoid nabilone.

Addiction (Abingdon, England), 2010

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Managing Nabilone-Induced Dizziness

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The pharmacologic treatment of anxiety disorders: a review of progress.

The Journal of clinical psychiatry, 2010

Research

Clinical pharmacology of nabilone, a cannabinol derivative.

Clinical pharmacology and therapeutics, 1975

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.